1. Introduction {#sec1}
===============

Worldwide, colorectal cancer (CRC) is the third most frequently diagnosed cancer in males and the second in females \[[@B1]\]. Australia and New Zealand, Europe and North America have the highest incidence rates of CRC worldwide, and Africa and South-Central Asia, the lowest \[[@B1], [@B2]\]. Over 75% of CRCs occur sporadically, with only 25% of patients having a family history of CRC \[[@B3]\].

Folate insufficiency has been suggested as one of the possible mechanism for CRC development and progression. DNA strand breaks, impaired DNA methylation and repair have been associated with folate deficiency and CRC \[[@B4]--[@B7]\]. There are many enzymes involved with folates and one-carbon metabolism; however, the *methylene tetrahydrofolate reductase (MTHFR)* enzyme is a key enzyme responsible for determining whether reduced folates are directed towards DNA methylation pathways or pyrimidine or purine synthesis \[[@B8]\]. In 1995, a variant of *MTHFR* enzyme was identified which causes a substitution of C to T at nucleotide 677 \[[@B9]\]. The *MTHFR C677T* homozygous variant (TT genotype) is thermolabile, and its activity is reduced by 70% compared to the wild type (CC genotype) \[[@B10]\]. This reduced enzyme activity causes an accumulation of plasma homocysteine and higher rates of thymidylate synthesis \[[@B10], [@B11]\].

The distribution of the TT genotype varies from country to country. In Europe, there would appear to be a north-south gradient with the distribution of the TT genotype lowest in the north \[[@B12], [@B13]\] while in Asia, the frequency is highest in China and lowest in India \[[@B12], [@B14]--[@B18]\]. In North America, African Americans have a much lower TT genotype frequency versus Caucasians \[[@B19]\]. Individuals with this variant are thought to be at greater risk for a number of diseases including cardiovascular disease, acute lymphocytic leukemia, and neural tube defects \[[@B10]\]. Some published studies have suggested that those with the TT genotype have a reduced risk of CRC versus those with the CC genotype (wild type) \[[@B20]--[@B28]\]; however, other studies have found an increased risk \[[@B29]--[@B31]\].

A second variant of the *MTHFR* enzyme, with a substitution of A to C at nucleotide 1298, has also been identified. Unlike the *MTHFR C677T* polymorphism, the enzyme activities of the variants of *MTHFR A1298C* polymorphism are not thermolabile, but the enzyme activity is reduced by approximately 40% of the wild type (AA genotype) in the variant genotype. Altered homocysteine levels have not been found in individuals with these variants \[[@B32]\]. The prevalence of the *1298*CC genotype varies, with the homozygous genotype found in 7--12% of Caucasians, in Europeans, 4--12%, while in China, Japan, and Hawaiian studies the prevalence ranged between 1 and 4% \[[@B32], [@B33]\].

The objective of this effort was to conduct a systematic review and meta-analysis of the published data to determine whether relationships exist between the various *MTHFR* polymorphisms and the incidence of CRC. A secondary objective was to examine whether there exists a relationship between the level of folate intake for each *MTHFR* genotype and the risk of CRC.

2. Methods and Materials {#sec2}
========================

2.1. Inclusion Criteria {#sec2.1}
-----------------------

We selected observational studies reporting on the polymorphisms of the *MTHFR C677T* and/or *A1298C* genes and the associated risk of CRC, colon, or rectal cancer in adult populations. Studies were also included if they reported on folate exposure (dietary or total) with at least two levels of folate intake and the associated rates of colorectal, colon and/or rectal cancer by genotype. Studies were excluded if they did not provide the information necessary to determine an odds ratio and 95% confidence interval for each genotype. No restrictions were placed on language of publication or country of study.

2.2. Search Strategy {#sec2.2}
--------------------

The databases MEDLINE, Embase, and Scopus on the OVID platform were searched from inception to May 2012. Both database-specific subject headings and text words were searched using the terms "folic acid" OR "folate" and "colorectal cancer" and "colorectal neoplasms" AND "methylenetetrahydrofolate reductase or *MTHFR* or C667T" limiting the results to humans only. The results of the search in each of the three databases were placed in a bibliography tool, and, in order to ensure blinding, an extract of author, title, and year information was made and uploaded into a spreadsheet for the purposes of title review. Title review was conducted by one reviewer (DAK) blinded to the journal of publication, place of research, and results, to determine which study articles to retrieve. The methods section of the selected journal articles were retrieved by other team members (MS and IM) not responsible for reviewing the journal articles. The method sections were reviewed by two independent reviewers (DAK, SJS) blinded to the journal of publication, place of research, and results as to their meeting the inclusion criteria. In case of disagreement between the two reviewers, a third reviewer served as a tiebreaker (GK). Previous reviews were also hand searched to identify other relevant publications to include.

2.3. Data Extraction {#sec2.3}
--------------------

Data extraction was carried out by one reviewer and independently checked for accuracy by a second reviewer. Data collected included the type of study, location, study inclusion and exclusion criteria, case and comparator group size, folate intake levels, odds ratio or risk ratio, the number, for both case and control, and percentage frequency of each genotype, relevant adjustments, and conclusions. The genotype distribution of the control group was evaluated for agreement with the Hardy-Weinberg equilibrium (HWE) using chi-squared with a significant level of 0.05 and the results incorporated into [Table 1](#tab1){ref-type="table"}.

The Downs and Black scoring instrument was used to determine the quality of the studies included in this paper. The Down and Black scoring tool provides a means to assess the quality of a study based on 5 subscales (1) reporting of the study results, (2) external validity for the purposes of assessing generalizability of the findings, (3) bias in measurement and outcomes, (4) bias in the selection of study subjects, and (5) the power of the study \[[@B34]\]. The score was independently calculated for each study by two team members. Disagreements were resolved by consensus. The last question on the Downs and Black tool relates to the power of the study. If *a priori* power calculation was reported in the paper, this question was scored with a one, otherwise, zero was scored.

2.4. Statistical Analysis {#sec2.4}
-------------------------

The meta-analysis for the genotype risk comparisons was performed using the inverse variance method under a random effects model, odds ratios (ORs) along with 95% confidence intervals (CIs) were used for the case control studies according to the DerSimonian and Laird method \[[@B35]\]. All identified studies with available data were included in the summary effect estimate for each genotype combination. For the meta-analysis of the risk of CRC associated with genotype, the wild type (*677*CC*or 1298*AA) was used as the reference group, and comparisons were made to either the heterozygous (*677*CT *or 1298*AC) or homozygous variant type (*677*TT *or 1298*CC). If studies grouped genotypes together for comparison purposes, or did not report ORs and 95% confidence intervals and the raw numbers were available in the paper, unadjusted ORs and associated 95% confidence intervals were calculated according to the method described by Silman and MacFarlane \[[@B36]\]. These are identified in [Table 1](#tab1){ref-type="table"} as "OR calculated, no adjustments" in the column titled Adjustments. The meta-analyses were performed using Review Manager 5.1 Software \[[@B45]\].

The meta-analyses for the comparison of high versus low folate intake and the associated risk of CRC were performed using the inverse variance method under a random effects model, odds ratios (ORs) along with 95% confidence intervals (CIs) were calculated according to the DerSimonian and Laird method \[[@B35]\]. All identified studies with available data were included in the summary effect estimate for each high versus low folate intake within a genotype. For those studies that compared folate intake by "quantile" and assessed the risk of CRC by genotype, many used the *677*CC or *677*CC/CT lowest folate intake quantile as the reference group to determine the OR for all genotypes and folate intake levels. For the purposes of this analysis, however, the desire was to compare the risk of CRC between the highest folate intake to lowest folate intake within a genotype. The method described by Hamling et al. and the associated MS Excel spreadsheet, which recalculates the adjusted odds ratios permitting alternative comparisons, were used to derive the ORs of highest compared to the lowest folate intake within the genotype \[[@B38], [@B39]\]. This analysis was performed using Microsoft Excel (Microsoft Corporation (2007), Redmond, WA, USA). An analysis of folate intake and CRC risk for the *MTHFR A1298C* gene was not possible due to an insufficient number of studies reporting on this data. In performing this analysis, the result from the highest "quantile" identified in the study was used to compare the lowest "quantile" in the study. Dietary folate intake for the lowest "quantile" ranged from a low of less than 115.6 to 406 mcg/day; the range for the highest was from 320 to 485 mcg/day or more. Although these ranges do overlap, they represent the highest and the lowest folate intake for the study population upon which the specific study odds ratios were derived. The meta-analyses were performed using Review Manager 5.1 Software \[[@B45]\].

Publication bias was assessed via the Begg and Mazumdar\'s rank correlation test, Egger\'s linear regression, and the Trim and Fill methods \[[@B40]--[@B42]\]. The assessment of publication bias was performed using the Comprehensive Meta-analysis (CMA) software (Biostat, Version 2.2, Englewood, NJ, USA) \[[@B43]\]. Summary effect estimates from CMA were compared with the RevMan results to ensure that they were both in agreement prior to executing the tests for publication bias.

Assessment of heterogeneity was performed using both Cochran\'s *χ*^2^ and *I*^2^. The Cochran\'s *χ*^2^ test assesses whether the differences in results are due to chance only \[[@B44]\]. Heterogeneity exists when the *P* value is low, that is, *P* \< 0.10 \[[@B44]\]. The *I*^2^ statistic is the percentage of variability in the effect estimates that is due to heterogeneity rather than chance. An *I*^2^ statistic value over 50% indicates that substantial heterogeneity may be present \[[@B44]\]. The analysis was performed using Review Manager 5.1 software \[[@B45]\].

Kruskal-Wallis was performed on the quality of the studies to determine whether there were differences in the quality of the studies based on the directionality of the outcome. For the purposes of this analysis, directionality was assessed as positive (statistical significant OR \> 1), neutral (nonsignificant OR), or negative (statistical significant OR ≤ 1). IBM\'s SPSS for Windows version 17 was used for the analysis (IBM SPSS, Version 17, Chicago, IL, USA).

The Forest plots of the *MTHFR C677T* and *A1298C* (Figures [2](#fig2){ref-type="fig"}[through 5](#fig5){ref-type="fig"}) were sorted according to the percentage of the comparator genotype (either *677*CT, *677*TT, *1298*AC, *or 1298*CC) in the control group, from highest to lowest, while the remaining Forest plots ([Figure 6](#fig6){ref-type="fig"}) were organized by increasing year of publication.

3. Results {#sec3}
==========

The pooled search resulted in 910 records. Of these 67 met our inclusion criteria, 10 studies were found on hand searching ([Figure 1](#fig1){ref-type="fig"}). Four identified studies were not included in the paper. In two studies, newborns comprised either all or part of the control group, which suggested that these studies were related to the determination of the prevalence of genotypes rather than risk of CRC since few newborns have had the opportunity to develop colorectal cancer \[[@B8], [@B46]\]. The remaining two studies did not report the separate case control numbers for each genotype; therefore, ORs could not be calculated for all genotypes; however the folate intake results, reported on in one of these studies, are included in the high versus low folate intake analysis \[[@B31], [@B47]\]. The majority of the studies included in the systematic review and meta-analysis were case control or nested case control studies, two cohort studies were identified ([Table 1](#tab1){ref-type="table"}). The meta-analysis results presented here update two previously published meta-analyses on *MTHFR* polymorphisms and the risk of colorectal cancer, that of Taioli et al. 2009 meta-analysis on the *MTHFR C677T* polymorphisms and Kono and Chen\'s 2005 meta-analysis on the *MTHFR A1298C* polymorphisms \[[@B48], [@B49]\]. All case control studies, with available data, were included in the meta-analysis, regardless of the quality score.

Study results were reported from twenty-five countries: Asia (China, India, Japan, South Korea, Taiwan, and Thailand), Australia, Europe (EPIC Cohort (10 European Centers), Czech Republic, Croatia, France, Germany, Hungary, Italy, Norway, Poland, Romania, Spain, Sweden, and United Kingdom), Latin America (Mexico), Middle East (Egypt, Iran, and Turkey), South America (Brazil), and USA. Six papers were written in another language with an English abstract: five in Chinese: the other in Spanish \[[@B31], [@B50], [@B52], [@B51], [@B53], [@B47]\]. When duplicate studies were found, for example, Nurses\' Health study and Health Professionals study, only the most recently published results were used in this analysis. There were five studies whose recruitment period was during the early days of folate fortification in USA; otherwise none of the studies were conducted in an environment of food fortification \[[@B55], [@B54], [@B56]\]. A blood sample was the most often used medium to assess genotype. There were two studies that used buccal samples as the tissue source for genotyping \[[@B18], [@B57]\].

3.1. Colorectal Cancer Risk and *MTHFR*C677T** Genotype {#sec3.1}
-------------------------------------------------------

For the comparison of *677*CT versus *677*CC, the summary risk estimate of the adjusted ORs was 1.02 (95% CI 0.95--1.10), *χ*^²^ = 210.34, df = 63, *P* \< 0.00001, *I*^²^ = 70% with significant heterogeneity ([Figure 2](#fig2){ref-type="fig"}). For the comparison of *677*TT versus *677*CC genotype, the summary risk estimate was 0.88 (95% CI 0.80--0.96) *χ*^²^ = 132.66, df = 61, *P* = 0.00001, *I*^²^ = 54% with significant heterogeneity ([Figure 3](#fig3){ref-type="fig"}). Two studies, Wang et al and Promthet et al., did not have any case participants with a TT genotype \[[@B58], [@B59]\].

### 3.1.1. Subgroup Analysis {#sec3.1.1}

Subgroup analysis was performed on sex. The pooled summary risk estimate of the studies reporting on sex for *677*CT versus *677*CC was 1.04 (95% CI 0.94--1.16), *χ*^²^ = 14.28, df = 10, *P* = 0.16, *I*^²^ = 30% and *677*TT versus *677*CC was 0.87 (95% CI 0.75--1.01), *χ*^²^ = 14.01, df = 10, *P* = 0.17, *I*^²^ = 29% with heterogeneity ([Table 2](#tab2){ref-type="table"}). The summary risk estimates for CRC risk between *677*CT versus *677*CC for men only were 1.12 (95% CI 0.94--1.34), *χ*^²^ = 18.68, df = 8, *P* = 0.02, *I*^2^ = 57% with significant heterogeneity ([Table 2](#tab2){ref-type="table"}) and for women only 0.98 (95% CI 0.85--1.12), *χ*^²^ = 7.63, df = 7, *P* = 0.37, *I*^2^ = 8% ([Table 2](#tab2){ref-type="table"}). The summary risk estimates for *677*TT versus *677*CC for men were 0.87 (95% CI 0.74--1.02), *χ*^²^ = 8.36, df = 8, *P* = 0.40, *I*^2^ = 4% ([Table 2](#tab2){ref-type="table"}) and for women only were 0.92 (95% CI 0.65--1.31), *χ*^²^ = 20.74, df = 7,  *P* = 0.004, *I*^2^ = 66% with significant heterogeneity ([Table 2](#tab2){ref-type="table"}).

Separate estimates for colon cancer and rectal cancer were also evaluated. For the summary risk estimates related to colon or rectal cancer, only those studies that reported separate results for either colon or rectal cancer were included. The pooled summary risk estimate of the studies reporting on either colon or rectal cancer only for *677*CT versus *677*CC was 1.01 (95% CI 0.95--1.08) *χ*^²^ = 23.65, df = 26,  *P* = 0.60, *I*^²^ = 0% and *677*TT versus *677*CC was 0.80 (95% CI 0.71--0.89) *χ*^²^ = 31.45, df = 23, *P* = 0.11, *I*^²^ = 27% with some heterogeneity evident ([Table 2](#tab2){ref-type="table"}). The summary risk estimates for *677*CT versus *677*CC colon cancer only were 1.01 (95% CI 0.93--1.10), *χ*^²^ = 11.23, df = 15, *P* = 0.74, *I*^2^ = 0% ([Table 2](#tab2){ref-type="table"}) and *677*TT versus *677*CC colon cancer only 0.76 (95% CI 0.64--0.91 *χ*^²^ = 22.79, df = 13,  *P* = 0.03, *I*^2^ = 43% ([Table 2](#tab2){ref-type="table"}). The summary risk estimates for *677*CT versus *677*CC rectal cancer only were 1.10 (95% CI 0.92--1.31), *χ*^²^ = 27.95,  df = 10, *P* = 0.002, *I*^2^ = 64% ([Table 2](#tab2){ref-type="table"}) and *677*TT versus *677*CC rectal cancer only 0.82 (95% CI 0.72--0.94), *χ*^²^ = 8.38, df = 9, *P* = 0.50, *I*^2^ = 0% ([Table 2](#tab2){ref-type="table"}).

### 3.1.2. Sensitivity Analysis {#sec3.1.2}

In an attempt to identify the studies contributing to the heterogeneity in the genotype summary risk effect results, sensitivity analysis was performed according the sequential algorithm proposed by Patsopoulos and colleagues \[[@B60]\]. This method involves sequentially dropping one study from the meta-analysis to determine the impact on the *I*^2^ statistic with the objective of identifying the study or studies that will reduce the *I*^2^ below a set threshold. Using this method, we were not successful in reducing the heterogeneity below the threshold value of an *I*^2^ value of less than 25%, which would have suggested that there was minimal heterogeneity in the results.

Given that the typical diets of Asian cultures can be substantially different from that of Europe and North America, separate analyses were conducted including just the studies in the Asian locations (China, India, Japan, South Korea, and Taiwan), separate from the European locations (Czech Republic, Croatia, European EPIC study, France, Germany, Hungary, Italy, Norway, Poland, Romania, Spain, Sweden, and United Kingdom), USA, and Middle East (Egypt, Iran, and Turkey) ([Table 2](#tab2){ref-type="table"}). The protective effect of the *677*TT genotype was sustained in each geography; however, only in the USA was the risk reduction significant with no heterogeneity.

A further analysis was performed by comparing the results based on the source of controls: either hospital patients or healthy persons. The heterogeneity was sustained ([Table 2](#tab2){ref-type="table"}).

### 3.1.3. Publication Bias {#sec3.1.3}

Publication bias was assessed using three different tests: Begg and Mazumdar\'s rank correlation test, Egger\'s linear regression, and the Trim and Fill methods. For the *MTHFR 677*CT genotype there may be some evidence for publication bias. The Begg and Mazumdar test returned a *P* value = 0.03, Egger\'s a *P* value = 0.005, and Trim and Fill found that an additional 12 studies would be necessary to form a symmetrical funnel plot. Whereas, for the *MTHFR 677*TT genotype, the Begg and Mazumdar test returned a *P* value = 0.33, Egger\'s a *P* value = 0.38, and Trim and Fill found that additional 4 studies would be necessary to form a symmetrical funnel plot, suggesting that publication bias may not be significant concern.

### 3.1.4. Correlation between Study Quality versus Results {#sec3.1.4}

There was no statistically significant difference found in the quality of the studies based on outcome (positive versus neutral versus negative) (*P* = 0.310).

3.2. Colorectal Cancer Risk and *MTHFR A1298C* Genotype {#sec3.2}
-------------------------------------------------------

For the comparison of *1298*AC versus *1298*AA, the summary risk estimate was 1.03 (95% CI 0.96--1.10), *χ*^²^ = 54.54, df = 39, *P* = 0.05, *I*^²^ = 28% with some heterogeneity ([Figure 4](#fig4){ref-type="fig"}). For the comparison of *1298*CC versus *1298*AA genotype, the summary risk estimate was 0.93 (95% CI 0.82--1.06), *χ*^²^ = 62.14, df = 38, *P* = 0.008, *I*^²^ = 39% with heterogeneity ([Figure 5](#fig5){ref-type="fig"}).

### 3.2.1. Sensitivity Analysis {#sec3.2.1}

In an attempt to identify the studies contributing to the heterogeneity in the genotype summary risk effect results for *1298*CC, the previously described process for sensitivity analysis was performed. The resulting summary effects estimate for *1298*CC versus *1298*AA was 1.04 (95% CI 0.94--1.14) *χ*^2^ = 32.17, df = 32, *P* = 0.46, *I*^²^ = 1% with no significant heterogeneity (data not shown). In this analysis, the studies contributing to the heterogeneity were conducted in Germany, India, and the USA \[[@B55], [@B61], [@B58], [@B54], [@B56]\].

### 3.2.2. Subgroup Analysis {#sec3.2.2}

There were an insufficient number of studies that reported CRC risk by sex; however, subgroups, by geography, and source of controls were performed.

Subgroup analysis by geography was performed for the *MTHFR A1298C* polymorphism according to the country groups previously described. There were an insufficient number of studies from the Middle East to include this location in the analysis. The subgroup analysis revealed that for European countries there was an associated, significant increased risk of CRC for those with the *1298*CC genotype, while Asian and USA studies suggest a significant associated decrease in risk ([Table 3](#tab3){ref-type="table"}). This variability in the associated risk of the *1298*CC genotype by geography was also noted by Kono and Chen in their meta-analysis \[[@B49]\].

A further analysis was performed by comparing the results based on the source of controls; either hospital patients or healthy persons. For the CC variant, the healthy controls had a nonsignificant reduced risk associated with CRC versus hospital control, within some increase in heterogeneity ([Table 3](#tab3){ref-type="table"}).

### 3.2.3. Publication Bias {#sec3.2.3}

The results of the statistical test for publication bias for the *MTHFR A1298C* polymorphisms suggest that publication bias may not be a concern. For *MTHFR 1298*AC, the Begg and Mazumdar test returned a *P* value = 0.24, Egger\'s a *P* value = 0.398, and Trim and Fill found that an additional 5 studies would be necessary to form a symmetrical funnel plot whereas, for the *1298*CC genotype, the Begg and Mazumdar test returned a *P* value = 0.88, Egger\'s a *P* value = 0.74, and Trim and Fill found that no additional studies would be necessary to form a symmetrical funnel plot.

3.3. Colorectal Cancer Risk and Combinations of the *MTHFR*C677T** and *A1298C* Genotypes {#sec3.3}
-----------------------------------------------------------------------------------------

The combinations of variants of the *MTHFR C677T* and *A1298C* genotypes are in linkage disequilibrium such that rarely are there individuals with the *677*TT*/1298*AC and *677*TT*/1298*CC combinations \[[@B49]\]. The results of the summary risk estimates for the remaining combinations are presented in [Table 4](#tab4){ref-type="table"}. The combination of *677*TT*/1298*AA was associated with lowest risk of CRC with a summary risk estimate of 0.77 (95% CI 0.58--1.03), *χ*^2^ = 19.00, df = 11, *P* = 0.06, *I*^²^ = 42% with significant heterogeneity.

3.4. Colorectal Cancer Risk, Comparison of High versus Low Folate Intake by Genotype {#sec3.4}
------------------------------------------------------------------------------------

Of the articles that met our inclusion criteria, there were 10 studies that reported on CRC risk by "quantile" of folate intake for the *MTHFR C677T*polymorphism; however, an insufficient number of studies reported on the folate intake for the *A1298C* polymorphism to complete the analysis for this polymorphism. A food frequency questionnaire (FFQ) was the usual method used to collect dietary intake information. Dietary information was captured for one to two years preceding diagnosis, or for the control group, at the time of enrolment in the study. The range of dietary folate intake, defined as folate from food sources, for the lowest "quantile" ranged from a low of less than 115.6 to 406 mcg/day; the range for the highest was from 320 to 485 mcg/day or more ([Table 5](#tab5){ref-type="table"}). The summary risk estimate for high versus low dietary folate intake for the *677*CC genotype was 0.76 (95% CI 0.62--0.94), *χ*^²^ = 2.96, df = 5, *P* = 0.71, *I*^²^ = 0%, for the *677*CT genotype 0.88 (95% CI 0.76--1.02), *χ*^²^ = 1.44, df = 2, *P* = 0.49, *I*^²^ = 0% and the *677*TT genotype 0.78 (95% CI 0.53--1.13), *χ*^²^ = 6.41, df = 6, *P* = 0.38, *I*^²^ = 6% ([Figure 6](#fig6){ref-type="fig"}).

Total folate intake information was also reported in some studies. Total folate was defined as folate from dietary and supplemental sources. The lowest "quantile" ranged from less than 264 to 450 mcg/day and the higher "quantile" ranged from 348 to 1583 mcg/day or more ([Table 5](#tab5){ref-type="table"}). The summary risk estimate for high versus low total folate intake for the *677*CC genotype was 0.70 (95% CI 0.56--0.89), *χ*^²^ = 0.06, df = 2,  *P* = 0.97, *I*^²^ = 0% and the *677*TT genotype 0.63 (95% CI 0.41--0.97), *χ*^²^ = 1.70, df = 3, *P* = 0.64, *I*^²^ = 0% ([Figure 6](#fig6){ref-type="fig"}). Only two studies had information available for the *677*CT genotype; therefore, the summary risk estimate was not determined.

4. Discussion {#sec4}
=============

The results of the analysis suggest that the homozygous variant genotype *MTHFR 677*TT confers a degree of protection against the development of CRC, affording an associated risk reduction of 12%. In contrast, the heterozygous genotype, *MTHFR 677*CT, was found to have the same risk as the genotype, *MTHFR 677*CC. These results are consistent with the previous meta-analysis completed in 2009 \[[@B48]\]. The thermolabile nature of *MTHFR 677*TT enzyme results in the reduced conversion of 5,10-methylene-tetrahydrofolate to 5-methyl-tetrahydrofolate, which acts as cofactor in the conversion of homocysteine to methionine, permitting a larger pool of 5,10-methylene-tetrahydrofolate for thymidylate biosynthesis. This protective effect would suggest that preferential availability of folates to contribute pyrimidine synthesis, and therefore a reduction in uracil misincorporation and subsequent DNA breaks, could be important in the pathogenesis of CRC \[[@B32]\].

This reduced risk of CRC for the *677*TT genotype was not supported by all of the included studies. In several individual studies, the *677*TT genotype was associated with an increased risk of CRC \[[@B29]--[@B31]\]. The authors of these studies theorized that conditions of low folate intake, which is characteristic of the diet in these countries (Brazil, Mexico), may explain the increased risk found between the *677*TT genotype and CRC. This would appear to be substantiated by the reduced risk apparent in the summary risk estimated for *677*CC and *677*TT genotypes when comparing high versus low total folate intake ([Figure 6](#fig6){ref-type="fig"}) and would suggest that folate intake can alter the risk of CRC. Evidence for the alteration of disease through adequate folic acid intake has been found in other situations. For example, a maternal *MTHFR 677*TT genotype is associated with a higher risk of having an offspring with a neural tube defect \[[@B62]\]. Increased folic acid supplementation, periconceptionally and during the first trimester, has been found to reduce this risk \[[@B63]\].

Many of the studies incorporated both men and women into the case control groups. However, far fewer studies stratified their results based on sex. Of the eleven studies included in this subgroup analysis, representing over 7,000 case/control study participants, only one reported significant OR based on sex and genotype, which was contrary to the summary results in this meta-analysis ([Table 2](#tab2){ref-type="table"}). Lightfoot et al. found that the men with the *677*CT genotype had a reduced risk of CRC, and women with the *677*TT genotype had an increased risk \[[@B64]\]. In the subgroup analysis on sex, the risk reduction of the *677*TT genotype and significant summary risk estimate for both sexes was no longer evident. This may represent lack of statistical power; it is possible that more studies are necessary to determine whether there may be a gender bias favoring one sex over another regarding the protective nature of the *677*TT genotype.

The *A1298C* polymorphisms would not appear to be associated with any substantial reduction in the associated risk of CRC. However, subgroup analysis did reveal some variability in the associated risk for the *1298*CC genotype, with lower risks associated with Asian and USA studies. What might be contributing to these geographical differences is unclear. Perhaps, as with the subgroup analysis by sex, additional studies with larger numbers of participants with this genotype are necessary to more clearly understand the relationship.

Many of the studies included in the high versus low folate intake meta-analysis compared the risk of CRC using the *677*CC or *677*CC/CT genotype and low folate intake as the reference group for the calculation of the odds ratio in other genotypes and folate intake "quantiles." Generally, the findings of these studies were that high folate intake and the *677*TT genotype were associated with a nonsignificant reduction in CRC risk versus low folate intake. This is the first study to perform a meta-analysis of the risk of CRC comparing high versus low folate intake within a genotype. The meta-analysis findings for the homozygous genotypes (*677*CC and *677*TT) indicate that there is greater risk reduction with higher levels of folate intake. The upper range of high folate intake reported in the studies was, generally, over the Institute of Medicine\'s (IOM) recommended daily intake (RDI) of 400 mcg/day and in one case over 1 mg/day \[[@B23], [@B65]\]. There were no clear boundaries in the definition of low folate intake versus high folate intake in this analysis as there was overlap in the ranges in daily folate amounts that defined the lowest folate intake versus the highest intake. This does prevent generalizing an amount of folate intake for each genotype that may be related to reducing colorectal cancer risk, which is a limitation of this analysis. Further, there is insufficient data to verify the shape (linear versus nonlinear) of the dose effect curve. More studies at this level of detail are necessary to provide further insight into the shape of the dose effect curve for folate and its associated impact on the risk of colorectal cancer.

The available studies used food frequency questionnaires (FFQs) or an adapted Coronary Artery Risk Development in Young Adults (CARDIAs) dietary history questionnaire to capture the food eaten on a regular basis; however, it is possible that not all of the folate food sources were captured thereby underestimating intake. Furthermore, tools such as the FFQ in case control studies are subject to recall bias since dietary intake was surveyed after a diagnosis of CRC. These two factors could lead to some under- or overreporting of folate intake resulting in misclassification of participants into their respective "quantiles." While mandatory folate fortification was implemented in the USA in 1998, none of the studies included in the meta-analysis on folate intake were conducted during times of folate fortification. Interestingly, a recent large observational study conducted in USA, after the mandated folate fortification period, found that higher folate intake levels were associated with a protective effect against CRC \[[@B66]\].

The studies included in the meta-analysis were conducted in twenty-five different countries. This is potentially both a strength and weakness of our analysis. Different countries represent different sources of folate and different food choice combinations, thus broadening the generalizability of our results. The potential weakness rests with the increased heterogeneity of some of the results. In the 2009 meta-analysis conducted by Taioli et al, their results indicate that in Asia the *677*TT genotype was afforded a significant risk reduction \[[@B48]\]. In our analysis, the *677*TT genotype is no longer significantly protective.

In conclusion, the results of this meta-analysis suggest that the *MTHFR 677*TT genotype is associated with a reduced risk of CRC. In addition, under conditions of high total folate intake, the associated risk of CRC is also reduced for both the *MTHFR 677* CC and TT genotypes.
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###### 

\(a\) Characteristic of studies included in the systematic review and meta analysis.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                                 Country                   Year   Study design           Source of controls   Recruitment period                     Cancer                Sex     Case/control   Distribution of *MTHFR C677T* genotype in controls   HWE (yes/no)   Distribution of *MTHFR A1298C*\   HWE (yes/no)   Adjustments                       
                                                                                                                                                                                                                                                                             genotype in controls                                                               
  ------------------------------------- ------------------------- ------ ---------------------- -------------------- -------------------------------------- --------------------- ------- -------------- ---------------------------------------------------- -------------- --------------------------------- -------------- ------------- ------ ------ ----- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Park et al. \[[@B67]\]                South Korea               1999   Case control           Healthy persons      Not reported                           CRC                   Both    200/460        30.4                                                 53.5           16.1                              No                                               Calculated OR, no adjustments

                                                                                                                                                                                                                                                                                                                                                                

  Delgado-Enciso et al. \[[@B15]\]      Mexico                    2001   Case control           Not reported         1997                                   CRC                   Both    74/110         30.9                                                 47.3           21.8                              Yes                                              Calculated OR, no adjustments

                                                                                                                                                                                                                                                                                                                                                                

  Keku et al. \[[@B55]\]                USA                       2002   Case control           Healthy persons      1996--2000                             Colon-Cauc            Both    555/875        49.2                                                 41.4           9.4                               Yes            52.5          38.5   9.3    Yes   Adjusted for sampling fraction, age, gender, and energy intake

                                                                                                                                                                                                                                                                                                                                                                

  Le Marchand et al. \[[@B23]\]         USA                       2002   Matched case control   Healthy persons      1994--1998                             CRC                   Both    727/727        39.2                                                 45             15.8                              Yes            58.2          36.0   5.8    No    Adjusted for age, gender, ethnicity, pack years of cigarette smoking, lifetime recreational physical activity, lifetime aspirin use, BMI 5 years ago, years of schooling, and intakes of nonstarch polysaccharides from vegetables and calcium from foods and supplements

                                                                                                                                                                                                                                                                                                                                                                

  Matsuo\                               Japan                     2002   Case control           Hospital patients    1999                                   CRC\                  Both    142/241\       33.6                                                 51.5           14.9                              Yes            65.1          31.1   3.7    Yes   Adjusted for age
  et al. \[[@B16]\]                                                                                                                                         colon\                        72/241\                                                                                                                                                               
                                                                                                                                                            rectal                        70/241                                                                                                                                                                

                                                                                                                                                                                                                                                                                                                                                                

  Shannon\                              Australia                 2002   Case control           Healthy persons      1985--1998                             CRC                   Both    501/\          44.2                                                 46.4           9.4                               Yes                                              Calculated OR, no adjustments
  et al. \[[@B68]\]                                                                                                                                                                       1,207                                                                                                                                                                 

                                                                                                                                                                                                                                                                                                                                                                

  Plaschke\                             Germany                   2003   Case control           Healthy persons      Not reported                           CRC                   Both    287/346        43.1                                                 45.9           11                                Yes            44.5          43.6   11.8   Yes   Adjusted for gender
  et al. \[[@B61]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Pufulete\                             United Kingdom            2003   Case control           Hospital patients    2000-2001                              CRC                   Both    304/352        54                                                   38             8                                 Yes            61.8          34.2   3.9    Yes   Adjusted for age, gender, BMI, smoking, and ROH intake.
  et al. \[[@B69]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Toffoli\                              Italy                     2003   Case control           Healthy persons      1999-2000                              Colon                 Both    276/279        29.7                                                 50.2           20.1                              Yes            47.7          43.4   9      Yes   Calculated OR, no adjustments
  et al. \[[@B70]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Jiang et al. \[[@B50]\]               China                     2004   Case control           Healthy person       1990--2002                             CRC                   Both    126/343        39.1                                                 42.4           18.5                              No             67.6          30.7   1.8    Yes   Adjusted for age and sex

                                                                                                                                                                                                                                                                                                                                                                

  Miao et al. \[[@B52]\]                China                     2005   Case control           Healthy persons      1999--2002                             CRC                   Both    198/420        31.7                                                 47.9           20.5                              Yes            67.1          31.4   1.4    No    None reported

                                                                                                                                                                                                                                                                                                                                                                

  Ulvik et al. \[[@B20]\]               Norway                    2004   Nested case control    Healthy persons      1992-1991                              CRC                   Both    2,168/\        49.9                                                 40.4           9.7                               Yes                                              Adjusted for age and gender
                                                                                                                                                                                          2,168                                                                                                                                                                 

                                                                                                                                                                                                                                                                                                                                                                

  Yin et al. \[[@B21]\]                 Japan                     2004   Case control           Hospital patients    2000--2003                             CRC                   Both    685/778        35.7                                                 47.2           17.1                              Yes            66.2          31.4   2.4    Yes   Adjusted for gender. 5-year age class, area and alcohol use

                                                                                                                                                                                                                                                                                                                                                                

  Jiang\                                China                     2005   Nested case control    Healthy persons      1989-1990                              Colon\                Both    52/338\        39.5                                                 42.2           18.3                              No             67.5          30.7   1.8    No    Adjusted for gender, age, folate, methionine, total energy intake, smoking status, and drinking status
  et al. \[[@B71]\]                                                                                                                                         rectal                        72/338                                                                                                                                                                

                                                                                                                                                                                                                                                                                                                                                                

  Landi et al. \[[@B72]\]               Spain                     2005   Case control           Hospital patients    1996--1998                             CRC                   Both    359/320        35.3                                                 45             19.7                              Yes            53.3          39.8   6.9    Yes   Adjusted for age and sex

                                                                                                                                                                                                                                                                                                                                                                

  Matsuo\                               Japan                     2005   Matched case control   Hospital patients    2001--2004                             CRC                   Both    257/771        37.5                                                 45.1           17.3                              Yes            62.5          33.5   4.0    Yes   Adjusted for age, sex, referral patterns, smoking BMI, physical, exercise and family history of CRC
  et al. \[[@B73]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Otani et al. \[[@B74]\]               Japan                     2005   Matched case control   Hospital patients    1998--2002                             CRC                   Both    107/224        23                                                   51.4           25.6                              Yes            69.6          28.1   2.2    Yes   Matching factors and adjusted for smoking, alcohol consumption, BMI, and total dietary fiber intake

                                                                                                                                                                                                                                                                                                                                                                

  Le Marchand\                          USA\                      2005   Nested case control    Healthy persons      1993--1996                             CRC\                  Both    822/\          48.9                                                 38.5           12.6                              No                                               Adjusted for age, gender, and ethnicity
  et al. \[[@B75]\]                     (Hawaii and California)                                                                                             colon\                        2,021                                                                                                                                                                 
                                                                                                                                                            rectal                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                                                                                                

  Battistelli et al. \[[@B76]\]         Italy                     2006   Case control           Healthy controls     Not reported                           CRC                   Both    93/100         30                                                   51             29                                Yes                                              Calculated OR, no adjustments

                                                                                                                                                                                                                                                                                                                                                                

  Van Guelpen\                          Sweden                    2006   Nested case control    Healthy persons      1985--2002                             CRC                   Both    226/437        52.8                                                 38.7           8.5                               Yes            45.9          42.0   12.1   Yes   Adjusted for BMI, smoking, recreational and occupational physical activity, and alcohol intake
  et al. \[[@B24]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Wang et al. \[[@B58]\]                India                     2006   Case control           Healthy persons      1999--2001                             CRC\                  Both    435/340        87.6                                                 12.4           0                                 Yes            36.1          46.4   17.5   Yes   Adjusted for gender, age household income, education, religion, mother tongue, smoking, drinking, chewing, and vegetarianism
                                                                                                                                                            colon\                                                                                                                                                                                              
                                                                                                                                                            rectal                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                                                                                                

  Lima\                                 Brazil                    2007   Case control           Healthy persons      1999--2001                             CRC                   Both    102/300        47.7                                                 42.3           10                                Yes            63.7          31.0   5.3    Yes   Adjusted for age, gender, and race
  et al. \[[@B77]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Chang\                                Taiwan                    2007   Matched case control   Hospital patients    2000-2001                              CRC                   Both    195/195        47.2                                                 44.6           8.2                               Yes            61.5          33.3   5.1    Yes   Matched on age and gender.
  et al. \[[@B78]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Curtin\                               USA                       2007   Matched case control   Healthy persons      1991--1994                             Colon                 Both    916/\          45.0                                                 43.5           11.5                              Yes            47.1          41.9   11     Yes   Calculated OR, no adjustments
  et al. \[[@B79]\]                                                                                                                                                                       1,972                                                                                                                                                                 

                                                                                                                                                                                                                                                                                                                                                                

  Hubner et al. \[[@B80]\]              United Kingdom            2007   Case control           Healthy controls     Not reported                           CRC                   Both    1,685/\        43.6                                                 44.3           12.1                              Yes                                              Adjusted for age, sex, family history, cancer location, stage, and grade
                                                                                                                                                                                          2,695                                                                                                                                                                 

                                                                                                                                                                                                                                                                                                                                                                

  Jin et al. \[[@B51]\]                 China                     2007   Case control           Healthy controls     2002--2005                             CRC                   Both    449/672        31.4                                                 48.4           20.2                              Yes                                              Adjusted for age, sex, drinking, BMI, smoking, and family history

                                                                                                                                                                                                                                                                                                                                                                

  Murtaugh\                             USA                       2007   Matched case control   Healthy persons      1997--2001                             Rectal-Men\           Both\   751/979        48.2\                                                40.1\          11.7\                             No             44.9          43.7   11.3   Yes   Adjusted for age, BMI, activity, energy, fiber, calcium, ibuprofen use, smoking, and other *MTHFR* genotype
  et al. \[[@B54]\]                                                                                                                                         Rectal-Women          Men\                   47.5                                                 41.4           11.1                                                                               
                                                                                                                                                                                  Women                                                                                                                                                                         

                                                                                                                                                                                                                                                                                                                                                                

  Osian et al. \[[@B81]\]               Romania                   2007   Matched case control   Hospital patients    2003--2005                             CRC                   Both    69/67          70.2                                                 25.4           4.5                               Yes            61.1          37.3   1.5    Yes   Matched on age and sex

                                                                                                                                                                                                                                                                                                                                                                

  Zeybek\                               Turkey                    2007   Case control           Hospital patients    2003--2005                             CRC                   Both    52/144         44.4                                                 45.1           10.4                              Yes                                              Calculated OR, no adjustments
  et al. \[[@B17]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Cao et al. \[[@B82]\]                 China                     2008   Matched case control   Healthy persons      2000--2002                             CRC                   Both    315/371        32.7                                                 49.5           17.8                              Yes            64.4          32.1   3.5    Yes   Matched on ethnicity, sex, and age

                                                                                                                                                                                                                                                                                                                                                                

  Küry et al. \[[@B83]\]                France                    2008   Matched case control   Healthy persons      2002--2006                             CRC                   Both    1,023/1,121    40.8                                                 45.9           13.3                              Yes            51.5          39.5   9      Yes   Matched on age and sex

                                                                                                                                                                                                                                                                                                                                                                

  Lightfoot\                            United Kingdom            2008   Matched case control   Hospital patients    1997--2000                             CRC                   Both    468/734        45.8                                                 46             8.3                               Yes            48.6          43.7   7.8    Yes   Adjusted for gender and age
  et al. \[[@B64]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Mokarram\                             Iran                      2008   Case control           Not reported         2003--2005                             Colon                 Both    151/81         49.4                                                 38.3           12.3                              Yes                                              Calculated OR, no adjustments
  et al. \[[@B84]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Sharp\                                United Kingdom\           2008   Matched case control   Healthy persons      1998--2000                             CRC                   Both    264/408        43.2                                                 44.9           11.9                              Yes            44.9          39.8   15.2   No    Adjusted for age, gender, family history of CRC, physical activity, NAAID use, total energy intake, and type of dietary supplements
  et al. \[[@B57]\]                     (Scotland)                                                                                                                                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                                                                                                

  Theodoratou\                          Scotland                  2008   Case control           Healthy persons      1999--2006                             CRC                   Both    2,028/\        45.3                                                 45.0           11.5                              Yes            45.8          44.1   10.1   Yes   Adjusted for age, sex, deprivation score, and family history risk
  et al. \[[@B85]\]                                                                                                                                                                       2,722                                                                                                                                                                 

                                                                                                                                                                                                                                                                                                                                                                

  Zhang\                                China                     2008   Matched case control   Hospital patients    2003--2005                             CRC                   Both    300/300        30.4                                                 46.5           23.1                              Yes            65.3          29.7   5      Yes   Adjusted for age, sex, education, family history, smoking, and drinking.
  et al. \[[@B53]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  El Awady\                             Egypt                     2009   Case control           Healthy persons      2004--2007                             CRC                   Both    35/68          65                                                   29             6                                 Yes            38            54     8      Yes   None reported
  et al. \[[@B86]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Gallegos-Arreola\                     Mexico                    2009   Case control           Healthy persons      2006--2008                             CRC                   Both    369/170        33.6                                                 34.1           32.2                              No                                               Calculated OR, no adjustments
  et al. \[[@B30]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Haghighi\                             Iran                      2009   Case control           Hospital patients    2004--2007                             CRC                   Both    234/257        36.6                                                 31.1           32.3                              Yes                                              None reported
  et al. \[[@B22]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Iacopetta\                            Australia                 2009   Matched case control   Healthy persons      2005--2007                             Proximal distal CRC   Both    850/958        45                                                   45             10                                Yes                                              Matched on gender, age, socioeconomic status, country of birth, educational level, and smoking status
  et al. \[[@B18]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Chandy\                               India                     2010   Matched case control   Healthy persons      2006--2008                             CRC                   Both    100/86         76.7                                                 22.1           1.2                               Yes            25.6          58.1   16.3   Yes   Matched on age and gender
  et al. \[[@B14]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Cui et al. \[[@B28]\]                 South Korea               2010   Case control           Hospital patients    2004--2008                             CRC                   Both    1,829/\        31.8                                                 50.7           17.5                              Yes                                              Adjusted for age and sex
                                                                                                                                                                                          1,700                                                                                                                                                                 

                                                                                                                                                                                                                                                                                                                                                                

  Eussen et al. \[[@B87]\]              EPIC                      2010   Nested case control    Healthy persons      1992--1998                             CRC                   Both    1,367/\        43.1                                                 45.5           11.5                              Yes            46.5          42.6   11.0   Yes   Calculated OR, no adjustments
                                                                                                                                                                                          2,325                                                                                                                                                                 

                                                                                                                                                                                                                                                                                                                                                                

  Fernández-Peralta et al. \[[@B88]\]   Spain                     2010   Matched case control   Healthy persons      1992--1996                             CRC                   Both    143/103        42.7                                                 48.6           8.7                               Yes            55.3          42.7   1.9    No    Matched on age and sex

                                                                                                                                                                                                                                                                                                                                                                

  Karpinski\                            Poland                    2010   Case control           Healthy persons      Not reported                           CRC                   Both    186/140        51                                                   39             10                                Yes                                              Adjusted for age and sex
  et al. \[[@B89]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Komlósi et al. \[[@B90]\]             Hungary                   2010   Case control           Healthy persons      2001--2007                             Colon\                Both\   476/461\       47\                                                  40\            13\                               Yes\                                             Adjusted for sex, age, and BMI\
                                                                                                                                                            rectal                Both    479/478        47                                                   41             12                                Yes                                              Adjusted for sex, age, and BMI

                                                                                                                                                                                                                                                                                                                                                                

  Naghib alhossaini\                    Iran                      2010   Case control           Not reported         Not reported                           CRC                   Both    151/230        42.4                                                 53             4.6                               Yes            42.5          45.7   11.8   Yes   Adjusted for age, sex, and smoking status
  et al. \[[@B91]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Promthet\                             Thailand                  2010   Matched case control   Healthy persons      2002--2006                             Colon                 Both    130/130        72.3                                                 23.8           3.9                               Yes            41.5          54.6   3.9    No    Matched on age and sex
  et al. \[[@B59]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Wettergren\                           Sweden                    2010   Case control           Healthy persons      1994--2004                             CRC                   Both    181/300        55.9                                                 35.8           8.4                               Yes                                              Calculated OR, no adjustments
  et al. \[[@B92]\]                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                

  Abuli et al. \[[@B93]\]               Spain                     2011   Matched case control   Healthy person       2000-2001                              CRC                   Both    515/515        38.1                                                 48             13.9                              Yes                                              Matched on age and sex

                                                                                                                                                                                                                                                                                                                                                                

  Guimarães et al. \[[@B94]\]           Brazil                    2011   Case control           Healthy persons      1992--2003                             CRC                   Both    113/188        48.9                                                 42.0           9                                 Yes            67.6          26.1   6.4    No    Adjusted for age, sex, and ethnic origin

                                                                                                                                                                                                                                                                                                                                                                

  Jokić et al. \[[@B95]\]               Croatia                   2011   Case control           Healthy persons      Not reported                           Colon                 Both    300/300        47.3                                                 43.3           9.3                               Yes            46.7          42.7   10.6   Yes    

                                                                                                                                                                                                                                                                                                                                                                

  Pardini\                              Czech Republic            2011   Case control           Hospital patients    2004--2006                             CRC                   Both    666/\          44.5                                                 45.6           9.9                               Yes            42.3          46.3   11.3   Yes   Adjusted for age and gender
  et al. \[[@B25]\]                                                                                                                                                                       1,377                                                                                                                                                                 

                                                                                                                                                                                                                                                                                                                                                                

  Kim et al. \[[@B26]\]                 South Korea               2011   Case control           Hospital patients    Not reported                           CRC                   Both    67/53          28.3                                                 39.6           32.1                              Yes            67.9          30.2   1.9    Yes   None reported

                                                                                                                                                                                                                                                                                                                                                                

  Sameer\                               Kashmiri\                 2011   Matched case control   Healthy persons      2008-2009                              CRC                   Both    86/160         75.6                                                 16.9           7.5                               No                                               None reported
  et al. \[[@B96]\]                     (India)                                                                                                                                                                                                                                                                                                                 

                                                                                                                                                                                                                                                                                                                                                                

  Prasad and Wilkhoo \[[@B97]\]         India                     2011   Case control           Healthy person       Not reported                           CRC                   Both    110/241        94.6                                                 5.0            0.4                               Yes                                              None reported

                                                                                                                                                                                                                                                                                                                                                                

  Zhu et al. \[[@B29]\]                 China                     2011   Case control           Healthy persons      2006--2008                             CRC                   Both    86/100         49.0                                                 41.0           10                                Yes                                              None reported

                                                                                                                                                                                                                                                                                                                                                                

  Kim et al. \[[@B27]\]                 South Korea               2012   Case control           Hospital patients    1998--2004                             CRC                   Both    787/656        31.3                                                 44.1           24.7                              No                                               Adjusted for age, sex, family history, multivitamin use, BMI, smoking status, and total energy

                                                                                                                                                                                                                                                                                                                                                                

  Lee et al. \[[@B56]\]                 USA                       2012   Nested case control    Healthy persons      Health professionals follow-up study   CRC                   Men     173/345        44                                                   39.9           16                                Yes            47.7          42.6   10.3   Yes   RR\'s reported, so OR\'s are calculated, no adjustments

                                                                                                                                                                                                                                                                                                                                                                

  Lee et al. \[[@B56]\]                 USA                       2012   Nested Case Control    Healthy persons      Physicians\' health study              CRC                   Men     240/408        47.7                                                 37.2           15                                Yes            45.8          42.2   12.1   Yes   RR\'s reported, so OR\'s are calculate, no adjustments

                                                                                                                                                                                                                                                                                                                                                                

  Lee et al. \[[@B56]\]                 USA                       2012   Nested Case Control    Healthy persons      Nurse Health Study                     CRC                   Women   189/377        46.7                                                 39.7           13.6                              Yes            51            38.3   10.7   Yes   RR\'s reported, so OR\'s are calculated no adjustments
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AA: African American, BMI: body mass index, Cauc: Caucasian CRC: colorectal cancer, HWE: Hardy Weinberg equilibrium, NSAID: nonsteroidal anti-inflammatory drug, OCP: oral contraceptive pill.

###### 

\(b\) Summary of cohorts studies.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                            Incidence rate ratio (RR) of CRC (95% CI)                                                
  ---------------------------- ------------- ------ -------- --------------------- ------------------- ----- ------ ----------- ----------- ------------------------------------------- -------------- -------------- -------------- --------------------------
  De Vogel et al. \[[@B98]\]   Netherlands   2009   Cohort   Healthy persons       Recruited in 1986   CRC   Both   689/1,793   7.3 years   1.23 (1.02--1.50)                           0.80\          0.89\          1.05\          Adjusted for age and sex
                                                                                                                                                                                        (0.56--1.15)   (0.72--1.09)   (0.79--1.38)   

                                                                                                                                                                                                                                     

  Heijmans et al. \[[@B99]\]   Netherlands   2003   Cohort   Elderly healthy men   Recruited in 1985   CRC   Both   18/793      10 years    1.16 (0.41--3.30)                           3.65\                                        Adjusted for age
                                                                                                                                                                                        (1.97--12.5)                                 
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Subgroup analysis for the *MTHFR C677T* polymorphism.

                              Number of studies   Number of participants in case/control   Summary effect estimate   95% CI     Tests for heterogeneity                                             
  --------------------------- ------------------- ---------------------------------------- ------------------------- ---------- ------------------------- ----------------------------------------- ----
  Subgroup by sex                                                                                                                                                                                   
                                                                                                                                                                                                    
  Pooled studies for sex                                                                                                                                  *I* ^2^ (%)                               
   CT versus CC               11                  1,650/1,833                              1,420/1,523               1.04       0.94--1.16                *χ*² = 14.28, df = 10 (*P* = 0.16)        30
   TT versus CC               11                  1,650/1,833                              326/425                   0.87       0.75--1.01                *χ*² = 14.01, df = 10 (*P* = 0.17)        29
  Men                                                                                                                                                                                                
   CT versus CC               9                   1,257/1,436^§^                           1,081/1,199^§^            1.12       0.94--1.34                *χ*² = 18.68, df = 8 (*P* = 0.02)         57
   TT versus CC               9                   1,257/1,436^§^                           271/346^§^                0.87       0.74--1.02                *χ*² = 8.36, df = 8 (*P* = 0.40)          4
  Women                                                                                                                                                                                              
   CT versus CC               8                   755/897^§^                               627/773^§^                0.98       0.85--1.12                *χ*² = 7.63, df = 7 (*P* = 0.37)          8
   TT versus CC               8                   755/897^§^                               162/217^§^                0.92       0.65--1.31                *χ*² = 20.74, df = 7 (*P* = 0.004)        66
                                                                                                                                                                                                    
  Subgroup by cancer type                                                                                                                                                                           
                                                                                                                                                                                                    
  Pooled studies                                                                                                                                                                                    
   CT versus CC               27                  3,735/6,767                              3,403/6,307               1.01       0.95--1.08                *χ*² = 23.65, df = 26 (*P* = 0.60)        0
   TT versus CC               24\*                3,735/6,767                              886/2,117                 **0.80**   0.71--0.89                *χ*² = 31.45, df = 23 (*P* = 0.11)        27
  Colon cancer studies                                                                                                                                                                              
   CT versus CC               16                  2,096/4,463                              1,933/4,090               1.01       0.93--1.10                *χ*² = 11.23, df = 15 (*P* = 0.74)        0
   TT versus CC               14\*\*              2,096/4,463                              452/1,352                 **0.76**   0.64--0.91                *χ*² = 22.79, df = 13 (*P* = 0.04)        43
  Rectal cancer studies                                                                                                                                                                             
   CT versus CC               11                  1,639/3,291                              1,470/2,996               1.10       0.92--1.31                *χ*² = 27.95, df = 10 (*P* = 0.002)       64
   TT versus CC               10                  1,639/3,291                              386/1,020                 **0.82**   0.72--0.94                *χ*² = 8.38, df = 9 (*P* = 0.50)          0
                                                                                                                                                                                                    
  Subgroup by location                                                                                                                                                                              
                                                                                                                                                                                                    
  Asian countries                                                                                                                                                                                   
   CT versus CC               22                  2,640/3,401                              2,985/3,903               0.98       0.89--1.06                *χ*² = 23.98, df = 21 (*P* = 0.29)        12
   TT versus CC               20\*\*              2,640/3,401                              1,001/1,565               0.83       0.69--1.01                *χ*² = 49.66, df = 19 (*P* = 0.0001)      62
  European countries                                                                                                                                                                                
   CT versus CC               22                  5,480/6,960                              5,374/6,857               1.00       0.87--1.13                *χ*² = 109.92, df = 21 (*P* \< 0.00001)   81
   TT versus CC               22                  5,480/6,960                              1,294/1,793               0.92       0.80--1.06                *χ*² = 43.74, df = 21 (*P* = 0.003)       52
  USA                                                                                                                                                                                                
   CT versus CC               8                   2,011/3,355                              1,932/2,997               0.98       0.90--1.07                *χ*² = 6.07, df = 7 (*P* = 0.53)          0
   TT versus CC               8                   2,011/3,355                              436/1,055                 **0.73**   0.63--0.84                *χ*² = 1.91, df = 7 (*P* = 0.96)          0
  Middle Eastern countries                                                                                                                                                                          
   CT versus CC               5                   277/374                                  274/302                   1.46       0.62--3.46                *χ*² = 45.30, df = 4 (*P* \< 0.00001)     91
   TT versus CC               5                   277/374                                  72/105                    0.69       0.42--1.13                *χ*² = 5.56, df = 4 (*P* = 0.23)          28
                                                                                                                                                                                                    
  Subgroup by control                                                                                                                                                                               
                                                                                                                                                                                                    
  Healthy person controls                                                                                                                                                                           
   CT versus CC               45                  8,706/12,958                             8,043/12,044              1.02       0.94--1.11                *χ*² = 154.26, df = 44 (*P* \< 0.00001)   71
   TT versus CC               43\*\*              8,706/12,958                             2,136/3,636               0.90       0.81--1.00                *χ*² = 88.37, df = 42 (*P* = 0.0001)      52
  Hospital patient controls                                                                                                                                                                         
   CT versus CC               16                  2,418/2,863                              2,932/3,619               0.93       0.83--1.05                *χ*² = 27.35, df = 15 (*P* = 0.03)        45
   TT versus CC               16                  2,418/2,863                              939/1,254                 0.82       0.68--1.00                *χ*² = 36.07, df = 15 (*P* = 0.002)       58

^§^Not all studies reported both case and control numbers.

\*There were two studies without TT genotype information, one study with rectal cancer data, and two studies with colon cancer data.

\*\*There were two studies that had 0 people for the TT genotype.

CRC: colorectal cancer.

###### 

Subgroup analysis for the *MTHFR A1298C* polymorphism.

                         Number of studies   Number of participants in case/control   Summary effect estimate   95% CI     Tests for heterogeneity                                        
  ---------------------- ------------------- ---------------------------------------- ------------------------- ---------- ------------------------- ------------------------------------ ---------
  Subgroup by location                                                                                                                                                                    
                                                                                                                                                                                          
  Asian countries                                                                                                                                                                         *I* (%)
   AC versus AA          15                  1,727/3,047                              991/1,615                 0.99       0.84--1.16                *χ*² = 26.56, df = 14 (*P* = 0.02)   47
   CC versus AA          14\*                1,727/3,047                              116/178                   **0.72**   0.55--0.93                *χ*² = 14.37, df = 13 (*P* = 0.35)   10
  European countries                                                                                                                                                                       
   AC versus AA          14                  2,971/4,119                              2,404/3,746               1.05       0.97--1.14                *χ*² = 14.78, df = 13 (*P* = 0.32)   12
   CC versus AA          14                  2,971/4,119                              683/908                   **1.14**   1.01--1.28                *χ*² = 13.13, df = 13 (*P* = 0.44)   1
  USA                                                                                                                                                                                      
   AC versus AA          7                   1,678/2,694                              1,365/2,244               0.99       0.88--1.11                *χ*² = 7.96, df = 6 (*P* = 0.24)     25
   CC versus AA          7                   1,678/2,694                              247/559                   **0.73**   0.57--0.92                *χ*² = 10.20, df = 6 (*P* = 0.12)    41
                                                                                                                                                                                          
  Subgroup by control                                                                                                                                                                     
                                                                                                                                                                                          
  Hospital controls                                                                                                                                                                        
   AC versus AA          12                  1,872/2,795                              1,258/1,874               1.05       0.95--1.16                *χ*² = 4.42, df = 11 (*P* = 0.96)    0
   CC versus AA          12                  1,872/2,795                              232/311                   1.12       0.88--1.42                *χ*²= 13.22, df = 11 (*P* = 0.28)    17
  Healthy controls                                                                                                                                                                         
   AC versus AA          27                  5,083/7,939                              3,926/6,325               1.02       0.93--1.11                *χ*²= 48.87, df = 26 (*P* = 0.004)   47
   CC versus AA          26\*                5,083/7,939                              912/1,439                 0.88       0.76--1.03                *χ*²= 45.33, df = 25 (*P* = 0.008)   45

\*There was one study that had no results for this genotype.

###### 

Summary effect estimate results for the *MTHFR C677T* and *A1298C* polymorphism combinations.

  Comparator genotype   Number of studies   Number of participants in case/control   Summary effect estimate   95% CI   Tests for heterogeneity                                         
  --------------------- ------------------- ---------------------------------------- ------------------------- -------- ------------------------- ------------------------------------- ---------
                                                                                                                                                                                        *I* (%)
  CC/AC                 12                  609/775                                  677/870                   0.96     0.82--1.11                *χ*² = 7.56, df = 11 (*P* = 0.75)     0
  CC/CC                 12                  609/775                                  180/312                   0.90     0.64--1.27                *χ*² = 21.33, df = 11 (*P* = 0.03)    48
  CT/AA                 12                  609/775                                  753/912                   0.99     0.86--1.15                *χ*² = 9.63, df = 11 (*P* = 0.56)     0
  CT/AC                 12                  609/775                                  491/678                   1.06     0.79--1.44                *χ*² = 30.68, df = 11 (*P* = 0.001)   64
  CT/CC                 5                   609/775                                  18/36                     1.40     0.33--6.03                *χ*² = 7.78, df = 4 (*P* = 0.10)      49
  TT/AA                 12                  609/775                                  311/465                   0.77     0.58--1.03                *χ*² = 19.00, df = 11 (*P* = 0.06)    42
  TT/AC                 4                   609/775                                  11/17                     N/a                                                                       
  TT/CC                 3                   609/775                                  0/6                       N/a                                                                       

^§^There was one study that did not report case control numbers for the combinations.

###### 

Case Control Studies: comparison of high versus low folate intake.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                           Country                       Year   Study design           Population of controls   Recruitment period   Cancer   Gender   Number of quantiles   Dietary folate (mcg/day)   Total folate (mcg/day)   Adjustments
  ------------------------------- ----------------------------- ------ ---------------------- ------------------------ -------------------- -------- -------- --------------------- -------------------------- ------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Chen et al. \[[@B100]\]         USA                           1996   Nested case control    Healthy persons          1986--1994           CRC      Men      3                     \<317 versus \>461                                  Adjusted for age, family history, and intake of folate, methionine, and alcohol

                                                                                                                                                                                                                                        

  Slattery et al. \[[@B101]\]     USA                           1999   Matched case control   Healthy persons          1991--1994           Colon    Both     3                     \<126 versus \>197\                                 Adjusted for age, BMI, physical activity, energy intake, dietary fiber, and smoking
                                                                                                                                                                                    per 1000 kcals                                      

                                                                                                                                                                                                                                        

  Le Marchand et al. \[[@B23]\]   USA                           2002   Matched case control   Healthy persons          1994--1998           CRC      Both     3                     \<278 versus \>372         \<336 versus \>1583      Adjusted for age, gender, ethnicity, pack years of cigarette smoking, lifetime recreational physical activity, lifetime aspirin use, BMI 5 years ago, years of schooling, and intakes of nonstarch polysaccharides from vegetables and calcium from foods and supplements

                                                                                                                                                                                                                                        

  Jiang et al. \[[@B71]\]         China                         2005   Nested case control    Healthy persons          1989-1990            Colon\   Both     4                     \<115.6 versus \>172\                               Adjusted for sex, age, methionine, smoking status drinking status, and zinc
                                                                                                                                            rectal                                  per 1000 kcals                                      

                                                                                                                                                                                                                                        

  Le Marchand et al. \[[@B75]\]   USA (Hawaii and California)   2005   Nested case control    Healthy persons          1993--1996           CRC      Both     3                     \<253 versus \>412         \<322 versus \>590       Adjusted for age, gender, and ethnicity

                                                                                                                                                                                                                                        

  Otani et al. \[[@B74]\]         Japan                         2005   Matched case control   Hospital patients        1998--2002           CRC      Both     3                     \<343 versus \>485                                  Matching factors and adjusted for smoking, alcohol consumption, BMI, and total dietary fiber intake

                                                                                                                                                                                                                                        

  Lightfoot et al. \[[@B64]\]     United Kingdom                2008   Matched case control   Hospital patients        1997--2000           CRC      Both     3                                                \<267 versus \>397       Adjusted for gender, and age

                                                                                                                                                                                                                                        

  Sharp et al. \[[@B57]\]         United Kingdom                2008   Matched case control   Healthy persons          1998--2000           CRC      Both     4                                                \<263.9 versus \>348.6   Adjusted for age, gender and total energy intake.

                                                                                                                                                                                                                                        

  Guerreiro et al. \[[@B31]\]     Portugal                      2008   Case control           Healthy persons          Not reported         CRC      Both     2                     ≤406.7\>                                            Adjusted for age, gender and CRC history

                                                                                                                                                                                                                                        

  Haghighi et al. \[[@B22]\]      Iran                          2009   Case control           Hospital patients        2004--2007           CRC      Both     2                     ≤320\>                     ≤450\>                   Not reported
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BMI: body mass index, CRC: colorectal cancer.

[^1]: Academic Editor: P. Vineis
